Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Toll‐like receptor 5 and 8 in hepatocellular carcinoma
Valtteri Kairaluoma, Niko Kemi, Heikki Huhta, et al.
Apmis (2021) Vol. 129, Iss. 8, pp. 470-479
Open Access | Times Cited: 12

Showing 12 citing articles:

Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives
Suprabhat Mukherjee, Ritwik Patra, Payam Behzadi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 67
Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease
Shaghayegh Khanmohammadi, Mohammad Shafi Kuchay
Pharmacological Research (2022) Vol. 185, pp. 106507-106507
Closed Access | Times Cited: 59
Pattern recognition receptors in the development of nonalcoholic fatty liver disease and progression to hepatocellular carcinoma: An emerging therapeutic strategy
Chen Huang, Youlian Zhou, Jiemin Cheng, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 16
Gut microbiota in MAFLD: therapeutic and diagnostic implications
Waleed Alghamdi, Mahmoud Mosli, Saleh A. Alqahtani
Therapeutic Advances in Endocrinology and Metabolism (2024) Vol. 15
Open Access | Times Cited: 5
Divergent functions of TLRs in gastrointestinal (GI) cancer: Overview of their diagnostic, prognostic and therapeutic value
Chou‐Yi Hsu, Saade Abdalkareem Jasim, Khetam H. Rasool, et al.
Seminars in Oncology (2025) Vol. 52, Iss. 3, pp. 152344-152344
Closed Access
RNA m5C methylation: a potential modulator of innate immune pathways in hepatocellular carcinoma
Sun Meng, Bai Jiangtao, Wang Haisong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Toll-like receptor-targeted nanoparticles: A powerful combination for tumor immunotherapy
Xin Zhi, Peipei Yang, Yunxue Xu, et al.
Nano Today (2023) Vol. 53, pp. 102003-102003
Closed Access | Times Cited: 5
TLR AND CANCER: THE ENIGMATIC CROSS TALK
Emna Fehri, Emna Ennaifer, M. Ardhaoui, et al.
IntechOpen eBooks (2024)
Open Access | Times Cited: 1
Chronic Inflammatory and Immune Microenvironment Promote Hepatocellular Carcinoma Evolution
Shimin Chen, Long Zhang, Yukun Chen, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 5287-5298
Open Access | Times Cited: 1
Multiple Factors Determine the Oncolytic or Carcinogenic Effects of TLRs Activation in Cancer
Ying-Xiang Yang, C Jin, Anthony E. T. Yeo, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-28
Open Access
Prognostic Value of an Immune Long Non-Coding RNA Signature in Liver Hepatocellular Carcinoma
Rui Kong, Nan Wang, Chun li Zhou, et al.
Journal of Microbiology and Biotechnology (2024) Vol. 34, Iss. 4, pp. 958-968
Open Access
Investigation of Anti-Liver Cancer Activity of the Herbal Drug FDY003 Using Network Pharmacology
Ho-Sung Lee, In‐Hee Lee, Sang‐In Park, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 1
Page 1

Scroll to top